GL1X · GenesisL1 explorer

Research workbench

ROS1 with astrazeneca ligand 1

Analyse ROS1 with astrazeneca ligand 1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7Z5W
Type
protein
Length
543 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase ROS
EC
2.7.10.1
UniProt
P08922
Ligands
IDW, SO4
Pockets
4 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1)protein27142% helix, 16% strandP08922
BProto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1)protein27242% helix, 17% strandP08922

Ligands and binding sites

  • IDW · ~{N}-[6-methyl-2-[(2~{S})-2-[3-(3-methylpyrazin-2-yl)-1,2-oxazol-5-yl]pyrrolidin-1-yl]pyrimidin-4-yl]-1,3-thiazol-2-amine · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13430.620.7849IDW
22970.590.7831IDW
3990.340.7315empty
4600.290.7416empty

Interfaces

1 interface between chains.

  • A–B · 774 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 7Z5W · ROS1 with AstraZeneca ligand 1 · the same entry in another collection · chain A against A, TM-score 1.00
  • P08922 · AlphaFold monomer V2.0 prediction for proto-oncogene tyrosine-protein kinase ROS (P08922) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.